openPR Logo
Press release

Cancer Genome Sequencing Market Size, Share | Industry Report, 2021-2027|Agilent Technologies, GE Healthcare Life Sciences, Johnson & Johnson

06-08-2021 03:46 PM CET | IT, New Media & Software

Press release from: QY Research, Inc

Cancer Genome Sequencing Market Size, Share | Industry Report,

Analysts at QY Research have authored an excellent research and analysis report on the global Cancer Genome Sequencing market. The report throws light on untapped markets and unexplored opportunities to help increase growth.

LOS ANGELES, United States: The report is an all-inclusive research study of the global Cancer Genome Sequencing market taking into account the growth factors, recent trends, developments, opportunities, and competitive landscape. The market analysts and researchers have done extensive analysis of the global Cancer Genome Sequencing market with the help of research methodologies such as PESTLE and Porter’s Five Forces analysis. They have provided accurate and reliable market data and useful recommendations with an aim to help the players gain an insight into the overall present and future market scenario. The Cancer Genome Sequencing report comprises in-depth study of the potential segments including product type, application, and end user and their contribution to the overall market size.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)

https://www.qyresearch.com/sample-form/form/2866965/global-cancer-genome-sequencing-market

Competitive landscape is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the global Cancer Genome Sequencing market to know the competition at both the domestic and global levels. Market experts have also offered the outline of every leading player of the global Cancer Genome Sequencing market, considering the key aspects such as areas of operation, production, and product portfolio. Additionally, companies in the report are studied based on the key factors such as company size, market share, market growth, revenue, production volume, and profits.

Key Players Mentioned in the Global Cancer Genome Sequencing Market Research Report: Agilent Technologies, GE Healthcare Life Sciences, Johnson & Johnson, LI-COR Biosciences, Abbott Laboratories, Beckman Coulter, Bayer, Hamilton Thorne Biosciences, Integrated DNA Technologies, Microchip Biotechnologies, Myriad Genetics, Commonwealth Biotechnologies, ZS Genetics, Pacific Biosciences

Global Cancer Genome Sequencing Market Segmentation by Product: Second Generation, Third Generation

Global Cancer Genome Sequencing Market Segmentation by Application: Treatment, Research

The Cancer Genome Sequencing Market report has been segregated based on distinct categories, such as product type, application, end user, and region. Each and every segment is evaluated on the basis of CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is estimated to generate opportunities in the global Cancer Genome Sequencing market in the forthcoming years. This segmental analysis will surely turn out to be a useful tool for the readers, stakeholders, and market participants to get a complete picture of the global Cancer Genome Sequencing market and its potential to grow in the years to come.

Key questions answered in the report:

What is the growth potential of the Cancer Genome Sequencing market?
Which product segment will grab a lion’s share?
Which regional market will emerge as a frontrunner in coming years?
Which application segment will grow at a robust rate?
What are the growth opportunities that may emerge in Cancer Genome Sequencing industry in the years to come?
What are the key challenges that the global Cancer Genome Sequencing market may face in future?
Which are the leading companies in the global Cancer Genome Sequencing market?
Which are the key trends positively impacting the market growth?
Which are the growth strategies considered by the players to sustain hold in the global Cancer Genome Sequencing market?
Request for customization in Report:

https://www.qyresearch.com/customize-request/form/2866965/global-cancer-genome-sequencing-market

 

TOC

1 Market Overview of Cancer Genome Sequencing
1.1 Cancer Genome Sequencing Market Overview

1.1.1 Cancer Genome Sequencing Product Scope

1.1.2 Cancer Genome Sequencing Market Status and Outlook
1.2 Global Cancer Genome Sequencing Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Cancer Genome Sequencing Market Size by Region (2016-2027)
1.4 Global Cancer Genome Sequencing Historic Market Size by Region (2016-2021)
1.5 Global Cancer Genome Sequencing Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Cancer Genome Sequencing Market Size (2016-2027)

1.6.1 North America Cancer Genome Sequencing Market Size (2016-2027)

1.6.2 Europe Cancer Genome Sequencing Market Size (2016-2027)

1.6.3 Asia-Pacific Cancer Genome Sequencing Market Size (2016-2027)

1.6.4 Latin America Cancer Genome Sequencing Market Size (2016-2027)

1.6.5 Middle East & Africa Cancer Genome Sequencing Market Size (2016-2027) 2 Cancer Genome Sequencing Market Overview by Type
2.1 Global Cancer Genome Sequencing Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Cancer Genome Sequencing Historic Market Size by Type (2016-2021)
2.3 Global Cancer Genome Sequencing Forecasted Market Size by Type (2022-2027)
2.4 Second Generation
2.5 Third Generation 3 Cancer Genome Sequencing Market Overview by Application
3.1 Global Cancer Genome Sequencing Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Cancer Genome Sequencing Historic Market Size by Application (2016-2021)
3.3 Global Cancer Genome Sequencing Forecasted Market Size by Application (2022-2027)
3.4 Treatment
3.5 Research 4 Cancer Genome Sequencing Competition Analysis by Players
4.1 Global Cancer Genome Sequencing Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Genome Sequencing as of 2020)
4.3 Date of Key Players Enter into Cancer Genome Sequencing Market
4.4 Global Top Players Cancer Genome Sequencing Headquarters and Area Served
4.5 Key Players Cancer Genome Sequencing Product Solution and Service
4.6 Competitive Status

4.6.1 Cancer Genome Sequencing Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data
5.1 Agilent Technologies

5.1.1 Agilent Technologies Profile

5.1.2 Agilent Technologies Main Business

5.1.3 Agilent Technologies Cancer Genome Sequencing Products, Services and Solutions

5.1.4 Agilent Technologies Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021)

5.1.5 Agilent Technologies Recent Developments
5.2 GE Healthcare Life Sciences

5.2.1 GE Healthcare Life Sciences Profile

5.2.2 GE Healthcare Life Sciences Main Business

5.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Products, Services and Solutions

5.2.4 GE Healthcare Life Sciences Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021)

5.2.5 GE Healthcare Life Sciences Recent Developments
5.3 Johnson & Johnson

5.3.1 Johnson & Johnson Profile

5.3.2 Johnson & Johnson Main Business

5.3.3 Johnson & Johnson Cancer Genome Sequencing Products, Services and Solutions

5.3.4 Johnson & Johnson Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021)

5.3.5 LI-COR Biosciences Recent Developments
5.4 LI-COR Biosciences

5.4.1 LI-COR Biosciences Profile

5.4.2 LI-COR Biosciences Main Business

5.4.3 LI-COR Biosciences Cancer Genome Sequencing Products, Services and Solutions

5.4.4 LI-COR Biosciences Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021)

5.4.5 LI-COR Biosciences Recent Developments
5.5 Abbott Laboratories

5.5.1 Abbott Laboratories Profile

5.5.2 Abbott Laboratories Main Business

5.5.3 Abbott Laboratories Cancer Genome Sequencing Products, Services and Solutions

5.5.4 Abbott Laboratories Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021)

5.5.5 Abbott Laboratories Recent Developments
5.6 Beckman Coulter

5.6.1 Beckman Coulter Profile

5.6.2 Beckman Coulter Main Business

5.6.3 Beckman Coulter Cancer Genome Sequencing Products, Services and Solutions

5.6.4 Beckman Coulter Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021)

5.6.5 Beckman Coulter Recent Developments
5.7 Bayer

5.7.1 Bayer Profile

5.7.2 Bayer Main Business

5.7.3 Bayer Cancer Genome Sequencing Products, Services and Solutions

5.7.4 Bayer Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021)

5.7.5 Bayer Recent Developments
5.8 Hamilton Thorne Biosciences

5.8.1 Hamilton Thorne Biosciences Profile

5.8.2 Hamilton Thorne Biosciences Main Business

5.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Products, Services and Solutions

5.8.4 Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021)

5.8.5 Hamilton Thorne Biosciences Recent Developments
5.9 Integrated DNA Technologies

5.9.1 Integrated DNA Technologies Profile

5.9.2 Integrated DNA Technologies Main Business

5.9.3 Integrated DNA Technologies Cancer Genome Sequencing Products, Services and Solutions

5.9.4 Integrated DNA Technologies Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021)

5.9.5 Integrated DNA Technologies Recent Developments
5.10 Microchip Biotechnologies

5.10.1 Microchip Biotechnologies Profile

5.10.2 Microchip Biotechnologies Main Business

5.10.3 Microchip Biotechnologies Cancer Genome Sequencing Products, Services and Solutions

5.10.4 Microchip Biotechnologies Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021)

5.10.5 Microchip Biotechnologies Recent Developments
5.11 Myriad Genetics

5.11.1 Myriad Genetics Profile

5.11.2 Myriad Genetics Main Business

5.11.3 Myriad Genetics Cancer Genome Sequencing Products, Services and Solutions

5.11.4 Myriad Genetics Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021)

5.11.5 Myriad Genetics Recent Developments
5.12 Commonwealth Biotechnologies

5.12.1 Commonwealth Biotechnologies Profile

5.12.2 Commonwealth Biotechnologies Main Business

5.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Products, Services and Solutions

5.12.4 Commonwealth Biotechnologies Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021)

5.12.5 Commonwealth Biotechnologies Recent Developments
5.13 ZS Genetics

5.13.1 ZS Genetics Profile

5.13.2 ZS Genetics Main Business

5.13.3 ZS Genetics Cancer Genome Sequencing Products, Services and Solutions

5.13.4 ZS Genetics Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021)

5.13.5 ZS Genetics Recent Developments
5.14 Pacific Biosciences

5.14.1 Pacific Biosciences Profile

5.14.2 Pacific Biosciences Main Business

5.14.3 Pacific Biosciences Cancer Genome Sequencing Products, Services and Solutions

5.14.4 Pacific Biosciences Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021)

5.14.5 Pacific Biosciences Recent Developments 6 North America
6.1 North America Cancer Genome Sequencing Market Size by Country (2016-2027)
6.2 United States
6.3 Canada 7 Europe
7.1 Europe Cancer Genome Sequencing Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe 8 Asia-Pacific
8.1 Asia-Pacific Cancer Genome Sequencing Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific 9 Latin America
9.1 Latin America Cancer Genome Sequencing Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America 10 Middle East & Africa
10.1 Middle East & Africa Cancer Genome Sequencing Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa 11 Cancer Genome Sequencing Market Dynamics
11.1 Cancer Genome Sequencing Industry Trends
11.2 Cancer Genome Sequencing Market Drivers
11.3 Cancer Genome Sequencing Market Challenges
11.4 Cancer Genome Sequencing Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source
13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

About Us

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Genome Sequencing Market Size, Share | Industry Report, 2021-2027|Agilent Technologies, GE Healthcare Life Sciences, Johnson & Johnson here

News-ID: 2300729 • Views: 320

More Releases from QY Research, Inc

Global Digital Logistics market: Key Vendors in the Market Space|Advantech Corpo …
Global Digital Logistics Market Overview: The latest report up for sale by QY Research demonstrates that the global Digital Logistics market is likely to garner a great pace in the coming years. Analysts have scrutinized the market drivers, confinements, risks, and openings present in the overall market. The report shows course the market is expected to take in the coming years along with its estimations. The careful examination is aimed at
Global Digital Intelligence Platform market: Novel Opportunities to Come up by 2 …
Global Digital Intelligence Platform Market Overview: The latest report up for sale by QY Research demonstrates that the global Digital Intelligence Platform market is likely to garner a great pace in the coming years. Analysts have scrutinized the market drivers, confinements, risks, and openings present in the overall market. The report shows course the market is expected to take in the coming years along with its estimations. The careful examination is
Global Digital Assurance market: Current Trends, Opportunities, and Challenges|C …
Global Digital Assurance Market Overview: The latest report up for sale by QY Research demonstrates that the global Digital Assurance market is likely to garner a great pace in the coming years. Analysts have scrutinized the market drivers, confinements, risks, and openings present in the overall market. The report shows course the market is expected to take in the coming years along with its estimations. The careful examination is aimed at
Global Desktop Virtualization market:Revenue, Sales, and Profit Margin Forecasts …
Global Desktop Virtualization Market Overview: The latest report up for sale by QY Research demonstrates that the global Desktop Virtualization market is likely to garner a great pace in the coming years. Analysts have scrutinized the market drivers, confinements, risks, and openings present in the overall market. The report shows course the market is expected to take in the coming years along with its estimations. The careful examination is aimed at

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and